Skip to content

First-in-class IKK-alpha Selective Inhibitors for Cancer Treatment

The first reported potent and selective IKK alpha inhibitors, with the lead compound achieving 60% tumour growth inhibition

Published: 26th August 2020
First-in-class IKK-alpha Selective Inhibitors for Cancer Treatment
Please note, header image is purely illustrative. Source: 10.2210/pdb5TQW/pdb, IKK-alpha, CC0
Seeking
  • Licensing
  • Development partner